We are a consulting and operating firm using the latest advancements in AI coupled with subject-matter experts in pharma (non-clinical, clinical, CMC, regulatory) to accelerate and reduce the cost of drug development
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Find investors for your startup like Acriba
Gritt sends AI-personalised outreach to each investor — from your Gmail